Authors: Govdi, Anastasiya I.; Sokolova, Nadezda V.; Sorokina, Irina V.; Baev, Dmitry S.; Tolstikova, Tatyana G.; Mamatyuk, Victor I.; Fadeev, Dmitry S.; Vasilevsky, Sergey F.; Nenajdenko, Valentine G.; MedChemComm; (2015); 10.1039/c4md00236a
The modification of betulinic acid derivatives bearing an ethynyl group at the C-3 position by different azidopeptides using Cu(I)-catalyzed alkyne-azide cycloaddition has been described. All obtained compounds were tested for their anti-inflammatory activity using a histamine-induced paw edema model. Betulinic acid–peptide conjugates containing histidine, alanine, tryptophan and isoleucine amino acid fragments were found to exhibit high anti-inflammatory activity, comparable to that of indomethacin. It has been shown by molecular docking that the obtained conjugates are incorporated into the binding site of the protein Keap1 Kelch-domain by their amino acid residues and form more non-covalent bonds, but have lower affinity than the initial triterpenoid core. It has been suggested that peptide moieties can modify the activity of the initial triterpenoid scaffold due to the change in the conformational and thermodynamic characteristics, which have influence on the binding of the compound to its molecular target.